Search

Your search keyword '"Kida, Kaneyuki"' showing total 9 results
Start Over Author "Kida, Kaneyuki" Publication Year Range Last 10 years
9 results on '"Kida, Kaneyuki"'

4. Evaluation of the modified carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae

Author

Kuchibiro, Tomokazu, Komatsu, Masaru, Yamasaki, Katsutoshi, Nakamura, Tatsuya, Nishio, Hisaaki, Nishi, Isao, Kimura, Keigo, Niki, Makoto, Ono, Tamotsu, Sueyoshi, Noriyuki, Kita, Machiko, Kida, Kaneyuki, Ohama, Masanobu, Satoh, Kaori, Toda, Hirofumi, Mizutani, Tetsu, Fukuda, Nozomi, Sawa, Kana, Nakai, Isako, Kofuku, Tomomi, Orita, Tamaki, Watari, Hideo, Shimura, Satoshi, Fukuda, Saori, Nakamura, Akihiro, and Wada, Yasunao

Published
2018
Full Text
View/download PDF

5. Laboratory surveillance of antimicrobial resistance and multidrug resistance among Streptococcus pneumoniae isolated in the Kinki region of Japan, 2001–2015

Author

Toda, Hirofumi, Satoh, Kaori, Komatsu, Masaru, Fukuda, Saori, Nakamura, Tatsuya, Jikimoto, Takumi, Nishio, Hisaaki, Yamasaki, Katsutoshi, Maede, Takuya, Orita, Tamaki, Sueyoshi, Noriyuki, Kita, Machiko, Toyokawa, Masahiro, Nishi, Isao, Akagi, Masahiro, Higuchi, Takefumi, Kofuku, Tomomi, Nakai, Isako, Ono, Tamotsu, Shimakawa, Koichi, Hikita, Yoshie, Moro, Kunihiko, Kida, Kaneyuki, Oohama, Masanobu, Wada, Yasunao, Tobe, Toru, Kamisako, Toshinori, and Tanaka, Yuji

Published
2018
Full Text
View/download PDF

7. CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic

Author

Matsumura, Yasufumi, Johnson, James R., Yamamoto, Masaki, Nagao, Miki, Tanaka, Michio, Takakura, Shunji, Ichiyama, Satoshi, Matsumura, Yasufumi, Yamamoto, Masaki, Nagao, Miki, Takakura, Shunji, Ichiyama, Satoshi, Fujita, Naohisa, Komori, Toshiaki, Yamada, Yukiji, Shimizu, Tsunehiro, Hayashi, Akihiko, Ono, Tamotsu, Watanabe, Harumi, Fujihara, Naoko, Higuchi, Takeshi, Moro, Kunihiko, Shigeta, Masayo, Kida, Kaneyuki, Terada, Hiromi, Tsuboi, Fusayuki, Sugimoto, Yoshihisa, and Fukumoto, Chiyoko

Published
2015
Full Text
View/download PDF

9. [The annual changes in antimicrobial susceptibility test results of Pseudomonas aeruginosa isolates from the Kinki district].

Author

Fukuda S, Komatsu M, Nakamura T, Jikimoto T, Nishio H, Yamasaki K, Satoh K, Toda H, Orita T, Sueyoshi N, Kita M, Nishi I, Akagi M, Higuchi T, Kofuku T, Nakai I, Ono T, Kida K, Ohama M, Watari H, Shimura S, Niki M, Kuchibiro T, and Wada Y

Subjects
Drug Resistance, Multiple, Bacterial, Humans, Japan, Microbial Sensitivity Tests, Pseudomonas aeruginosa drug effects, Anti-Bacterial Agents pharmacology, Pseudomonas aeruginosa isolation & purification
Abstract

A study was conducted of the 1,225 Pseudomonas aeruginosa strains that were isolated at 20 medical institutions in the Kinki district between 2011 and 2013 to determine their antimicrobial susceptibility and to characterize the strains of multidrug-resistant Pseudomonas aeruginosa (MDRP) and the metallo-β-lactamase (MBL) -producing strains. The MIC50/MIC90 values (μg/mL) of the various antimicrobial agents were as follows: imipenem, 2/>8; meropenem, 1/>8; doripenem, 0.5/8; biapenem, 1/>8; tazobactam/piperacillin, 8/>64; piperacillin, 8/>64; sulbactam/cefoperazone, 8/64; cefepime, 4/16; cefozopran, 2/>16; aztreonam, 8/>16; amikacin, 4/16; levofloxacin, 1/>4; and ciprofloxacin, 0.25/>2. From the viewpoint of the annual changes in the susceptibility rates (according to the CLSI guidelines [M100-S22]), the susceptibility to tazobactam/piperacillin, piperacillin, cefepime, cefozopran and aztreonam decreased in 2013. On the other hand, two antimicrobial agents showed high susceptibility rates each year; amikacin (94.0-95.6%) showed the highest rate, followed by doripenem (80.3-82.6%). With the exception of amikacin, there were substantial inter-institutional differences in antimicrobial susceptibility. In comparison to the previous CLSI guidelines (M100-S21), the new CLSI guidelines (M100-S22) on the use of carbapenems and penicillins show that the MIC80 has been affected. The MDRP detection rates in 2011, 2012 and 2013 were 1.8% (8 strains), 1.8% (8 strains), and 2.8% (10 strains), respectively. The MBL detection rates were as follows: bla(VIM-2), 0.2% (1 strain) in 2011; bla(IMP-1), 0.9% (4 strains) in 2012, and 1.7% (6 strains, including bla(IMP-1) [3 strains], bla(IMP-2) [2 strains] and bla(VIM-2) [1 strain]) in 2013.

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results